Bir sonraki

Otomatik oynatma

Dr. Brentjens on CD19-Targeted T Cells in CLL and ALL

2 Görünümler • 07/14/23
Pay
gömmek
administrator
administrator
Aboneler
0

Renier J. Brentjens, MD, PhD, associate professor, chief, Cellular Therapeutics Center, Memorial Sloan-Kettering Cancer Center, discusses clinical responses in patients with chronic lymphoblastic leukemia (CLL) or acute lymphoblastic leukemia (ALL) following infusion with CD19-Targeted T Cells.

Daha fazla göster
0 Yorumlar sort Göre sırala
Facebook Yorumları

Bir sonraki

Otomatik oynatma